0 companies in this challenge area
Biosensing, diagnostics, medical devices, and health technologies at the intersection of biology and engineering.
Our 6 biotech members sit at the intersection of hardware engineering and life sciences -- building brain-computer interfaces, point-of-care diagnostics, and novel therapeutic platforms. Newlab's labs and regulatory navigation support help these companies move from research to product.
Point-of-care diagnostics: $15B. Biosensors: $12B. Brain-computer interfaces: $3B. Medical devices: $20B.
Wearable and implantable biosensors. Brain-computer interfaces going commercial. Rapid point-of-care testing. Personalized diagnostics. AI-powered health monitoring.